Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,785 papers from all fields of science
Search
Sign In
Create Free Account
P276-00
Known as:
CDK Inhibitor P276-00
A flavone and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. P276-00 selectively binds to and inhibits Cdk4/cyclin…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Cyclin Dependent Kinase Inhibitor P276
Cyclin-Dependent Kinases
NCIt Antineoplastic Agent Terminology
Negative Regulation of Cell Cycle
Expand
Broader (1)
Flavones
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Abstract GS5-00: Long-term influence of estrogen plus progestin and estrogen alone use on breast cancer incidence: The Women's Health Initiative randomized trials
R. Chlebowski
,
G. Anderson
,
+14 authors
R. Prentice
2020
Corpus ID: 216298616
Background: Breast cancer outcomes from the Women’s Health Initiative (WHI) Estrogen plus Progestin and Estrogen-alone trials…
Expand
2015
2015
P276 Prévalence et association de l’obésité et hypertension artérielle dans la région des Grands Lacs
J. Safari
,
L. Maroyi
,
D. Bichet
2015
Corpus ID: 76198719
2014
2014
A tabu search algorithm for routing and spectrum allocation in elastic optical networks
Róża Goścień
,
M. Klinkowski
,
K. Walkowiak
International Conference on Transparent Optical…
2014
Corpus ID: 16982030
In this paper we present a tabu search-based algorithm, which is dedicated to solving the routing and spectrum allocation problem…
Expand
2012
2012
A toolbox for developing bioinformatics software
Kristian Rother
,
W. Potrzebowski
,
Tomasz Puton
,
Magdalena Rother
,
E. Wywial
,
J. Bujnicki
Briefings Bioinform.
2012
Corpus ID: 875952
Creating useful software is a major activity of many scientists, including bioinformaticians. Nevertheless, software development…
Expand
2012
2012
Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers
M. Rathos
,
Kavita Joshi
,
Harshal Khanwalkar
,
S. Manohar
,
K. Joshi
Journal of Translational Medicine
2012
Corpus ID: 255857432
P276-00 is a novel cyclin-dependent kinase inhibitor currently in Phase II clinical trials. Gemcitabine is a standard of care for…
Expand
2008
2008
CPL 03-00-008 - Combustible Dust National Emphasis Program (Reissued)
Osha Instruction
2008
Corpus ID: 110945324
Purpose: This instruction contains policies and procedures for inspecting workplaces that create or handle combustible dusts. In…
Expand
Highly Cited
2007
Highly Cited
2007
P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models
K. Joshi
,
M. Rathos
,
+8 authors
Somesh D. Sharma
Molecular Cancer Therapeutics
2007
Corpus ID: 7586045
P276-00, a flavone that inhibits cyclin-dependent kinases, has been identified by us recently as a novel antineoplastic agent. In…
Expand
2005
2005
Plant height and yield components of six genotypes of the Vigna genus in two locations of Venezuela
P. Madriz
,
R. Parra
,
A. Leal
2005
Corpus ID: 55930940
With the aim of characterizing the agronomical behaviour, yield components and its correlation to the yield in genotypes of the…
Expand
2004
2004
Subclinical vitamin A deficiency in Israeli-Bedouin toddlers
C. Coles
,
A. Levy
,
+4 authors
D. Fraser
European Journal of Clinical Nutrition
2004
Corpus ID: 7329072
Objective: This study was designed to estimate the prevalence of and evaluate risk factors for subclinical vitamin A deficiency…
Expand
2001
2001
Mapping DSP applications onto self-timed multiprocessors
S. Bhattacharyya
,
N. Bambha
,
M. Khandelia
,
V. Kianzad
Conference Record of Thirty-Fifth Asilomar…
2001
Corpus ID: 14427079
Self-timed scheduling is an attractive implementation style for multiprocessor DSP systems due to its ability to exploit…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE